Marlène Thomas
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 6
- Cancer Diagnosis and Treatment 5
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Julie Hill (1 shared paper)Timothy Jay Price (1 shared paper)Oleg A. Gladkov (1 shared paper)Jian Xu (1 shared paper)Keun‐Wook Lee (1 shared paper)Josef Rüschoff (1 shared paper)Oliver Stoß (1 shared paper)Eric Van Cutsem (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)PROTEOMICS (2 papers)The Oncologist (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Marlène Thomas
28 papers receiving 1.3k citations
Marlène Thomas's Hit Papers
Peers
Comparison fields: 5 of 54
- Oncology 561
- Cancer Research 211
- Pulmonary and Respiratory Medicine 402
- Radiology, Nuclear Medicine and Imaging 148
- Spectroscopy 34
Countries citing papers authored by Marlène Thomas
This map shows the geographic impact of Marlène Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlène Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlène Thomas more than expected).
Fields of papers citing papers by Marlène Thomas
This network shows the impact of papers produced by Marlène Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlène Thomas. The network helps show where Marlène Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Marlène Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Hit paper breakdown → | 2014 | 491 |
| 2 | 2014 | 187 | |
| 3 | 2015 | 63 | |
| 4 | 2017 | 60 | |
| 5 | 2020 | 58 | |
| 6 | 2013 | 55 | |
| 7 | 2021 | 49 | |
| 8 | 2022 | 49 | |
| 9 | 2014 | 48 | |
| 10 | 2024 | 37 | |
| 11 | 2017 | 35 | |
| 12 | 2022 | 32 | |
| 13 | 2023 | 22 | |
| 14 | 2005 | 21 | |
| 15 | 2008 | 17 | |
| 16 | 2015 | 15 | |
| 17 | 2013 | 13 | |
| 18 | 2024 | 13 | |
| 19 | 2015 | 9 | |
| 20 | 2013 | 8 |
About Marlène Thomas
Marlène Thomas is a scholar working on Oncology, Cancer Research, Statistics and Probability, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Cancer Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (3 papers), Statistical Methods in Clinical Trials (3 papers), Lung Cancer Treatments and Mutations (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (561 citations), Cancer Research (211 citations), Pulmonary and Respiratory Medicine (402 citations), Radiology, Nuclear Medicine and Imaging (148 citations) and Spectroscopy (34 citations). Marlène Thomas has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Julie Hill, Timothy Jay Price, Oleg A. Gladkov, Jian Xu, Keun‐Wook Lee, Josef Rüschoff, Oliver Stoß, Eric Van Cutsem, Shunchang Jiao and Vivian Ng. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, PROTEOMICS, The Oncologist and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.